Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer. / Federspiel, Birgitte Hartnack; Hansen, Carsten Palnaes; Vainer, Ben; Hasselby, Jane Preuss; Bardram, Linda; Knigge, Ulrich.

In: Ugeskrift for Laeger, Vol. 172, No. 43, 25.10.2010, p. 2946-50.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Federspiel, BH, Hansen, CP, Vainer, B, Hasselby, JP, Bardram, L & Knigge, U 2010, 'Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer', Ugeskrift for Laeger, vol. 172, no. 43, pp. 2946-50.

APA

Federspiel, B. H., Hansen, C. P., Vainer, B., Hasselby, J. P., Bardram, L., & Knigge, U. (2010). Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer. Ugeskrift for Laeger, 172(43), 2946-50.

Vancouver

Federspiel BH, Hansen CP, Vainer B, Hasselby JP, Bardram L, Knigge U. Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer. Ugeskrift for Laeger. 2010 Oct 25;172(43):2946-50.

Author

Federspiel, Birgitte Hartnack ; Hansen, Carsten Palnaes ; Vainer, Ben ; Hasselby, Jane Preuss ; Bardram, Linda ; Knigge, Ulrich. / Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer. In: Ugeskrift for Laeger. 2010 ; Vol. 172, No. 43. pp. 2946-50.

Bibtex

@article{0cefc7aca76e42cca25ddfba8cc79b01,
title = "Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer",
abstract = "Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.",
author = "Federspiel, {Birgitte Hartnack} and Hansen, {Carsten Palnaes} and Ben Vainer and Hasselby, {Jane Preuss} and Linda Bardram and Ulrich Knigge",
year = "2010",
month = oct,
day = "25",
language = "Dansk",
volume = "172",
pages = "2946--50",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "43",

}

RIS

TY - JOUR

T1 - Incidens, patologi og klinik ved neuroendokrine gastrointestinale tumorer

AU - Federspiel, Birgitte Hartnack

AU - Hansen, Carsten Palnaes

AU - Vainer, Ben

AU - Hasselby, Jane Preuss

AU - Bardram, Linda

AU - Knigge, Ulrich

PY - 2010/10/25

Y1 - 2010/10/25

N2 - Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.

AB - Gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) are unusual. Their incidence, the different tumour types and growth patterns are described. The tumours should be classified according to the WHO 2000 classification and the Tumour Node Metastasis classification according to guidelines from the European Neuroendocrine Tumour Society. Important parameters are localization, size, hormonal secretion, mitotic index, and proliferation index (Ki-67) of the primary tumour. Patients with GEP NET should be referred to as few centres as possible in order to obtain the highest experience and the greatest understanding of these tumours thereby achieving the capacity to offer patients the best possible treatment and to create optimal conditions for research.

M3 - Tidsskriftartikel

VL - 172

SP - 2946

EP - 2950

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 43

ER -

ID: 34052503